McKesson Corp.
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
0.29%
Market Cap
75.92 Bil.
P/E Ratio
22.55
Dividend Yield
0.37 %
Earnings per Share
33.11 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 636.8 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:47 PM | |
| DAILY VOLUME (UNITS) | 38 | |
| DAILY HIGH / LOW | 638.8 | 628.8 |
| PREV. DAY'S PRICE | 631.6 | (06/02) |
| CHANGE DAY BEFORE | +5.20 | 0.82 % |
| 52 WEEK HIGH / LOW | 860.8 (03/04) | 562.8 (08/13) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 42.97 | 37.88 | 33.11 | 23.97 | 20.64 |
| DIVIDENDS PER SHARE | 3.07 | 3.06 | 2.74 | 2.56 | 2.21 |
| DIVIDEND YIELD IN % | - | - | 0.37 % | 0.41 % | 0.45 % |
| DIVIDEND GROWTH IN % | - | - | 6.75 % | 15.78 % | 10.16 % |
| PRICE - EARNINGS RATIO | 15.10 | 17.13 | 22.55 | 26.16 | 23.98 |
| PRICE - BOOK RATIO | - | - | - | - | - |
| PRICE - SALES RATIO | - | - | 0.27 | 0.24 | 0.23 |
| PRICE - CASH FLOW RATIO | - | - | 17.45 | 14.17 | 16.69 |
Master Data
| WKN | 893953 |
| ISIN | US58155Q1031 |
| SYMBOL | MCK |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | McKesson |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 120.20 Mil. |
| MARKET CAPITALISATION | 75.92 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.59 % | -8.86 % | -25.38 % | -13.48 % | 0.29 % | 73.52 % | 303.45 % | -10.11 % |
| HIGH | 653.80 | 693.80 | 860.80 | 860.80 | 860.80 | 860.80 | 860.80 | 860.80 |
| LOW | 626.60 | 615.00 | 615.00 | 615.00 | 562.80 | 357.00 | 154.75 | 615.00 |
Dividend
per share
Company profile
McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Structured products for McKesson Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.